As Governments Continue to Spend For Healthcare Infra Development, Automated Dialysis Concentrated Production Systems Market to Witness Promising Growth, notes Fact.MR
17 Feb 2021
Dialysis concentrates are prepared according to the patient’s requirement and help in regulating their acid-base and electrolyte balance and removing metabolic waste products from the blood. Automated dialysis concentrated production systems are used to produce these concentrates. The production in the automated dialysis concentrated production systems include bicarbonate concentrate production, acid concentrate production, and specific modifiers for hemodialysis. Automated dialysis concentrated production systems have storage tanks and mixing tanks where the dialysis concentrates are prepared. The storage tanks in an automated dialysis concentrated production system are connected to the delivery systems for dialysis centers.
For more insights into the Market, Request a Sample of this Report -
What are New Trends Emerging in Global Market?
Automated dialysis concentrated production systems market is highly driven by hemodialysis. Hemodialysis is one of the most common dialysis methods performed for patients suffering from chronic kidney diseases and related ailments. According to the National Center for Chronic Disease Prevention and Health Promotion, there were approximately 118,000 people in the US in 2014 who started the treatment for ESRD and 662,000 were on chronic dialysis or had a kidney transplant. Open automated dialysis concentrated production system is expected to grow at the fastest rate owing to a better and improved validation of the dialysis fluid and water treatment and production of fluid according to the required quality.
Automated dialysis concentrated production systems market is highly driven by growing incidences of chronic kidney diseases and kidney-related ailments. Increase in private investment and venture funding as support to the manufacturing of more advanced production systems is also expected to drive the automated dialysis concentrated production systems market over the forecast period. Government spending on health care, especially for patients dealing with chronic kidney diseases has been improving and could drive the demand for automated dialysis concentrated production systems over the forecast period. However, there is low awareness about kidney-related ailments which might hinder market growth for automated dialysis concentrated production systems. The procedure is also costly, making it highly unaffordable for middle-income and poor-economy countries. This could also hinder the automated dialysis concentrated production systems market over the forecast period.
View Detailed Table of Content Here:
How Will North America Continue Dominating Global Market in Future?
A vital factor which is driving the North America market for automated dialysis concentrated production systems is the growing awareness about the availability of automated dialysis concentrated production systems for treatment of various kidney diseases and kidney related ailments. North America’s automated dialysis concentrated production systems market is also expected to grow at a faster rate owing to good healthcare spending and healthcare infrastructure. Europe is one of the leading regions for automated dialysis concentrated production systems market because of the high incidence and prevalence of kidney diseases and consistent rise in geriatric population. Lack of awareness about kidney diseases and dialysis will hinder the Asia-Pacific’s market for automated dialysis concentrated production systems over the forecast period.
The major market participants operating in the global automated dialysis concentrated production systems market are B. Braun Melsungen AG, REN MED MEDICAL PRODUCTS & TRADE LTD. CO., Nipro Renal Solutions, Unipharm JSC, and FLG Automation AG.
Request Methodology on this Research Report for specific research solutions:
Explore Fact.MR’s Lucid Healthcare Coverage
Drug Discovery Services Market – Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services. Introduction of advanced technology in the drug discovery process is also the major driver in the market growth.
Preimplantation Genetic Testing Market – The preimplantation genetic testing market is likely to be influenced by a combination of macroeconomic and microeconomic factors. Due to the changing lifestyle, increasing number of people are suffering from genetic disorders or diseases. Hence there has been a significant demand growth in preimplantation genetic testing.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Sudip Saha
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Organizations
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.